4-<i>O</i>-Methylhonokiol Influences Normal Cardiovascular Development in Medaka Embryo

• Main Authors: Santu K. Singha, Ilias Muhammad, Mohamed Ali Ibrahim, Mei Wang, Nicole M. Ashpole, Zia Shariat-Madar
• Format: Article
• Language: English
• Published: MDPI AG 2019-01-01
• Series: Molecules
• Subjects: cardiomyogenesis; factor VII; factor X; inflammation; thrombosis; vasculogenesis; herbal medicine
• Online Access: https://www.mdpi.com/1420-3049/24/3/475

Although 4-<i>O</i>-Methylhonokiol (MH) effects on neuronal and immune cells have been established, it is still unclear whether MH can cause a change in the structure and function of the cardiovascular system. The overarching goal of this study was to evaluate the effects of MH, isolated from <i>Magnolia grandiflora</i>, on the development of the heart and vasculature in a Japanese medaka model in vivo to predict human health risks. We analyzed the toxicity of MH in different life-stages of medaka embryos. MH uptake into medaka embryos was quantified. The LC₅₀ of two different exposure windows (stages 9&#8315;36 (0&#8315;6 days post fertilization (dpf)) and 25&#8315;36 (2&#8315;6 dpf)) were 5.3 &#177; 0.1 &#956;M and 9.9 &#177; 0.2 &#956;M. Survival, deformities, days to hatch, and larval locomotor response were quantified. Wnt 1 was overexpressed in MH-treated embryos indicating deregulation of the Wnt signaling pathway, which was associated with spinal and cardiac ventricle deformities. Overexpression of major proinflammatory mediators and biomarkers of the heart were detected. Our results indicated that the differential sensitivity of MH in the embryos was developmental stage-specific. Furthermore, this study demonstrated that certain molecules can serve as promising markers at the transcriptional and phenotypical levels, responding to absorption of MH in the developing embryo.